Abstract
Ziad Mallat retraced his research work based on the analysis of atheroma in mouse models with mutated genes involved in inflammatory functions. He showed how his work has led to the development of therapeutic trials currently underway, involving the use of anti-inflammatory T regulatory lymphocytes to slow down atheroma.
